"Community Hospital's affiliation with Huntsman Cancer Institute brings together Huntsman's world-renowned expertise along with Grand Valley Oncology's regional leadership beginning a partnership that has opened up a broader range of options for cancer patients locally. ◾Cancer care, based on comprehensive research and specialized cancer expertise close to home ◾Access to more clinical trials for more cancers to give patients more options ◾Collaboration by national and regional cancer specialists to offer customized treatment plans Grand Valley Oncology is committed to improving our patients and their families' quality of life right here on the Western Slope. We are a Commission on Cancer accredited program."

During the past decade, Grand Valley Oncology conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 8 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grand Valley Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grand Valley Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "American Cancer Society, Inc." with 1 trials as a collaborator, "American Society of Clinical Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Grand Valley Oncology" are "Invasive Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "Stage II Breast Cancer" (4 trials), "Stage IIA Breast Cancer" (4 trials) and "Stage IIB Breast Cancer" (4 trials). Many other conditions were trialed in "Grand Valley Oncology" in a lesser frequency.

Most popular intervention types in "Grand Valley Oncology" are "Drug" (31 trials), "Other" (28 trials), "Procedure" (21 trials), "Biological" (16 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (12 trials), "Laboratory Biomarker Analysis" (11 trials), "Computed Tomography" (10 trials), "Quality-of-Life Assessment" (9 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Grand Valley Oncology" are 42 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grand Valley Oncology". undefined are not yet recruiting, 12 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Grand Valley Oncology, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grand Valley Oncology, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".